The collaboration will create a better patient focused approach to drug development and the delivery of medicines, devices and treatment protocols. 

7i will use Confirmit’s text analytics tool, Confirmit Genius, to listen to what patients and healthcare professionals (HCPs) are saying publicly about treatments. It will collate and analyse this unstructured data from sources such as patient forums and blogs to identify themes and sentiments.

All data is gathered in strict accordance with GDPR regulations (including informed consent) and market research codes of conduct.

Andrew Sellick, managing director at 7i Group, said: “Publicly sharing thoughts, opinions and experiences online is increasingly part of everyday life. It is often the environment in which patients and HCPs are most likely to express their views on a medicine or device in a ‘real world’ setting.”